Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Sep 27, 2021; 13(9): 1025-1038
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1025
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1025
Figure 4 Overall long-term prognosis between two groups in patients with distal cholangiocarcinoma.
A: Overall disease-free survival curve of two groups of patients; B: Overall survival curve of two groups of patients. CA19-9: carbohydrate antigen 19-9; GGT: γ-glutamyltransferase.
- Citation: Jiang T, Lyu SC, Zhou L, Wang J, Li H, He Q, Lang R. Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma. World J Gastrointest Surg 2021; 13(9): 1025-1038
- URL: https://www.wjgnet.com/1948-9366/full/v13/i9/1025.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i9.1025